Correlation Between Bolt Biotherapeutics and Neximmune
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and Neximmune, you can compare the effects of market volatilities on Bolt Biotherapeutics and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Neximmune.
Diversification Opportunities for Bolt Biotherapeutics and Neximmune
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bolt and Neximmune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Neximmune go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and Neximmune
If you would invest (100.00) in Neximmune on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Neximmune or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Bolt Biotherapeutics vs. Neximmune
Performance |
Timeline |
Bolt Biotherapeutics |
Neximmune |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Bolt Biotherapeutics and Neximmune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bolt Biotherapeutics and Neximmune
The main advantage of trading using opposite Bolt Biotherapeutics and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |